Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 study.

MLA

Antoniotti, Carlotta, et al. “Tumour Mutational Burden, Microsatellite Instability, and Actionable Alterations in Metastatic Colorectal Cancer: Next-Generation Sequencing Results of TRIBE2 Study.” European Journal of Cancer, vol. 155, Sept. 2021, pp. 73–84. EBSCOhost, https://doi.org/10.1016/j.ejca.2021.06.037.

APA

Antoniotti, C., Korn, W. M., Marmorino, F., Rossini, D., Lonardi, S., Masi, G., Randon, G., Conca, V., Boccaccino, A., Tomasello, G., Passardi, A., Swensen, J., Ugolini, C., Oberley, M., Tamburini, E., Casagrande, M., Domenyuk, V., Fontanini, G., Giordano, M., & Abraham, J. (2021). Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 study. European Journal of Cancer, 155, 73–84. https://doi.org/10.1016/j.ejca.2021.06.037

Chicago

Antoniotti, Carlotta, W. Michael Korn, Federica Marmorino, Daniele Rossini, Sara Lonardi, Gianluca Masi, Giovanni Randon, et al. 2021. “Tumour Mutational Burden, Microsatellite Instability, and Actionable Alterations in Metastatic Colorectal Cancer: Next-Generation Sequencing Results of TRIBE2 Study.” European Journal of Cancer 155 (September): 73–84. doi:10.1016/j.ejca.2021.06.037.